文献速递肝胆胰外科围术期管理与 ERAS急腹症与外科感染

胰十二指肠切除术前内引流患者三代头孢预防手术部位感染

Third-generation cephalosporin for antimicrobial prophylaxis in pancreatoduodenectomy in patients with internal preoperative biliary drainage.
PubMed 文献 · Surgery · 2018-10-26

回顾性研究纳入138例胰十二指肠切除术前接受内镜下胆道支架置入且术前胆汁培养结果未知的患者,2010-2014年用头孢唑林(n=69),2014-2017年用头孢曲松(n=69)。头孢曲松组总体手术部位感染发生率显著低于头孢唑林组(Clavien-Dindo≥II级28% vs 52%,P=.005;≥IIIa级20% vs 41%,P=.016)。多因素分析显示头孢唑林预防给药与更高手术部位感染发生率相关。

要点

  • 术前内镜下胆道引流且胆汁培养未知者,三代头孢可降低胰十二指肠切除术后手术部位感染。
  • 头孢唑林组感染患者围术期培养多为肠杆菌科,对头孢唑林天然耐药、多对头孢曲松敏感。
  • 头孢唑林预防给药与总体手术部位感染风险升高独立相关。

核心结论

  • 在术前接受内镜下胆道支架置入且术前胆汁培养结果未知的患者中,三代头孢(头孢曲松)预防给药较头孢唑林降低了胰十二指肠切除术后手术部位感染发生率。

研究设计与样本

  • 回顾性研究,纳入138例接受胰十二指肠切除术并术前内镜下胆道支架置入、近期术前胆汁培养结果不可得的患者;2010-2014年予头孢唑林(n=69),2014-2017年予头孢曲松(n=69)。

主要发现

  • 总体手术部位感染发生率头孢曲松组低于头孢唑林组:Clavien-Dindo≥II级为28% vs 52%(P=.005),Clavien-Dindo≥IIIa级为20% vs 41%(P=.016)。
  • 多因素分析显示头孢唑林预防给药与总体手术部位感染发生率升高相关:Clavien-Dindo≥II级OR 2.56(P=.019),≥IIIa级OR 3.03(P=.020)。
  • 头孢唑林组围术期培养阳性的患者以肠杆菌科为主,对头孢唑林天然耐药,多数对头孢曲松敏感。

临床怎么用

  • 对于胰十二指肠切除术前已行内镜下胆道支架置入且术前胆汁培养结果未知的患者,可考虑选用三代头孢作为预防性抗生素。

局限性

  • 本研究为单中心回顾性研究,样本量138例,抗生素选择按时期分组,可能存在时代偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of the present study was to investigate whether the incidence of surgical site infection after pancreatoduodenectomy decreased after changing the prophylactic antibiotic to a third-generation cephalosporin in patients with unknown preoperative bile culture results after biliary drainage. METHODS: In a retrospective study of 138 pancreatoduodenectomy patients who underwent endoscopic biliary stenting and for whom recent preoperative bile culture results were unavailable, cefazolin sodium hydrate was administered as perioperative prophylactic antibiotic therapy from 2010 to 2014 (n = 69); whereas ceftriaxone was administered from 2014 to 2017 (n = 69) based on the results of institutional culture surveillance. The incidence of surgical site infection was compared between the two groups and the risk factor of surgical site infection was also evaluated. RESULTS: The incidence of overall surgical site infection in the ceftriaxone group was significantly lower than that in the cefazolin sodium hydrate group for both Clavien-Dindo grade ≥II (28% versus 52%, P = .005) and Clavien-Dindo grade ≥IIIa (20% vs 41%, P = .016). A multivariate analysis revealed that the prophylactic administration of cefazolin sodium hydrate was associated with a higher incidence of overall surgical site infection in both Clavien-Dindo grade ≥II and Clavien-Dindo grade ≥IIIa (odds ratio 2.56, P = .019; odds ratio 3.03, P = .020, respectively). In the cefazolin sodium hydrate group, most of the patients with positive perioperative cultures had Enterobacteriaceae, which were intrinsically resistant to cefazolin sodium hydrate, and most were susceptible to ceftriaxone. CONCLUSION: The prophylactic administration of third-generation cephalosporin reduced the incidence of surgical site infection after pancreatoduodenectomy in patients who underwent preoperative endoscopic biliary stenting.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Sano S, Sugiura T, Kawamura I, et al. Third-generation cephalosporin for antimicrobial prophylaxis in pancreatoduodenectomy in patients with internal preoperative biliary drainage. Surgery. 2018. PMID: 30803620. doi:10.1016/j.surg.2018.09.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。